Sustained Structural Stability in Seropositive Rheumatoid Arthritis With Overlap Features Under JAK Inhibition
Authors/Creators
Description
Description
RheumaView™ is a validator-governed radiographic reporting and analytics platform designed to solve a fundamental problem in musculoskeletal imaging: the gap between what clinicians need for longitudinal decision-making and what researchers need for reproducible, audit-ready endpoints.
This case illustration demonstrates the platform's dual-layer architecture using a real-world 4.5-year longitudinal series in seropositive rheumatoid arthritis with overlap features. The same imaging data generates two distinct outputs: a Structured Clinical Report for EMR documentation and treatment decisions, and a De-identified Research Analytics Addendum with standardized ordinal scores, longitudinal delta tables, symmetry metrics, and stability indices suitable for registry aggregation, pragmatic trials, and pharmaceutical outcomes research.
Key capabilities demonstrated:
- Deterministic reproducibility: Identical inputs yield identical outputs—eliminating inter-reader variability that plagues conventional radiographic scoring and inflates sample size requirements in clinical trials
- Governed data handling: Explicit suppression of metrics when required inputs are unavailable (e.g., DEXA), with reason codes rather than estimation or silent omission
- Projection-aware confidence: Findings constrained by acquisition limitations are documented with calibrated certainty rather than false precision
- Phenotype separation: Distal/thumb osteoarthritic drift cleanly distinguished from inflammatory erosive progression, enabling precise cohort definitions
- Longitudinal signal extraction: "Structure-stable" disease documented across years of fluctuating clinical symptoms—an endpoint-relevant signal invisible to conventional narrative reporting
Beyond this case: The RheumaView research engine supports substantially broader analytic domains including axial spine and sacroiliac joint analytics, multi-modal fusion (radiograph–DEXA–MRI correlation), metabolic bone modeling, immunotherapy response tracking, pediatric developmental normalization, and neuro-structural concordance mapping. The platform is positioned for integration with pharmaceutical trials, CRO workflows, imaging core labs, and real-world evidence registries.
Related Publications:
- Deterministic Radiographic Scoring in Inflammatory Arthritis (DOI: 10.5281/zenodo.14538029)
- Validator-Governed Deterministic Radiographic Pipelines: The RheumaView™ Architecture (DOI: 10.5281/zenodo.18002981)
- Longitudinal Structural Stability in Overlapping Spondyloarthritis (DOI: 10.5281/zenodo.18014565)
Patent Status: U.S. patent applications filed. Collaboration inquiries: contact_us@rheumaview.com
Notes
This manuscript is presented as an operational, real-world demonstration of validator-governed longitudinal radiographic reporting and documentation discipline.
Its purpose is to show how a governed workflow can
(i) inventory projections across timepoints, (ii) enforce completeness and quality checks, (iii) constrain interpretation when inputs are incomplete, and
(iv) generate audit-ready, reproducible structural signals suitable for longitudinal monitoring and technical communication.
The case materials are used only as an illustrative substrate to stress-test the workflow under everyday constraints (variable projection sets, mixed quality, missing adjunct inputs). Where information is insufficient, outputs are intentionally suppressed or marked as “not computed,” rather than imputed.
Accordingly, nothing in this manuscript should be interpreted as evidence of therapeutic efficacy, comparative benefit, or causal treatment effect for any medication, device, or clinical strategy.
This is not a clinical trial, not an outcomes study, not a comparative effectiveness analysis, and not a validation of diagnostic performance. No claims are made regarding sensitivity/specificity, prognostic value, disease-modifying effect, or patient outcome improvement.
Any references to treatment context are provided solely to explain why longitudinal imaging questions arose in routine care and to frame the operational relevance of reproducible reporting.
Clinical decisions must rely on the treating clinician’s judgment, full clinical context, and established standards of care; this manuscript does not provide medical advice or treatment guidance.
Files
RheumaView_Case_Illustration dual platform.pdf
Files
(4.0 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:87dc2cd04ebfd306b6645c21cda22f65
|
4.0 MB | Preview Download |
Additional details
Additional titles
- Alternative title
- A 4.5-Year Longitudinal Radiographic Case Using RheumaView™ Clinical and Research Outputs
Related works
- Cites
- 10.5281/zenodo.18014566 (DOI)
- 10.5281/zenodo.18002981 (DOI)
- 10.5281/zenodo.17994028 (DOI)
Dates
- Issued
-
2025-12-23